Tiens Biotech Group (NYSE AMEX:TBV)

Going forward, our primary requirements for cash consist of:

• construction by Life Resources of new research and development, manufacturing and logistic facilities, and administrative offices;
• the continued production of existing products and general overhead and personnel related expenses to support these activities;
• the development costs of new products; and
• expansion of production scale to meet the demands of our markets.

Should the cashflow from operation be insufficient in the next twelve months, the company has also established credit facility with local commercial bank. However, at this time management is not able to determine the exact financing amount needed.